BCAX

SEC source: 0001628280-26-034087 · wk-form4_1778616247.xml · derivative · entry 1

Schelman William · CIK 0002132269 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2036-05-08

F1 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following May 8, 2026, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-028054 · wk-form4_1777420165.xml · derivative · entry 3

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,913

Underlying: Common Stock · 5,500 shares

Expires 2023-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-028054 · wk-form4_1777420165.xml · nonDerivative · entry 2

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,286

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.51 to $23.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-028054 · wk-form4_1777420165.xml · nonDerivative · entry 1

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,786

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-026604 · wk-form4_1776891211.xml · derivative · entry 3

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,744

Underlying: Common Stock · 9,200 shares

Expires 2033-04-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following April 5, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-026604 · wk-form4_1776891211.xml · nonDerivative · entry 2

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,355

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.68 to $23.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-026604 · wk-form4_1776891211.xml · nonDerivative · entry 1

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

SEC source: 0001628280-26-026089 · wk-form4_1776727626.xml · derivative · entry 9

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 161,107

Underlying: Common Stock · 15,000 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F6 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-026089 · wk-form4_1776727626.xml · nonDerivative · entry 5

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 362,152

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.355 to $23.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-026089 · wk-form4_1776727626.xml · nonDerivative · entry 4

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 377,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-026089 · wk-form4_1776727626.xml · derivative · entry 8

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 558,432

Underlying: Common Stock · 7,080 shares

Expires 2033-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following December 14, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-026089 · wk-form4_1776727626.xml · derivative · entry 7

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,546

Underlying: Common Stock · 7,454 shares

Expires 2033-04-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following April 5, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-026089 · wk-form4_1776727626.xml · derivative · entry 6

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,684

Underlying: Common Stock · 8,226 shares

Expires 2032-10-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following October 4, 2022, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-026089 · wk-form4_1776727626.xml · nonDerivative · entry 3

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 362,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-026089 · wk-form4_1776727626.xml · nonDerivative · entry 2

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 355,072

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-026089 · wk-form4_1776727626.xml · nonDerivative · entry 1

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 347,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-025817 · wk-form4_1776459315.xml · derivative · entry 4

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,334

Underlying: Common Stock · 8,000 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-025817 · wk-form4_1776459315.xml · nonDerivative · entry 3

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 196,141

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.58 to $23.255, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-025817 · wk-form4_1776459315.xml · nonDerivative · entry 2

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 200,641

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.58 to $23.255, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-025817 · wk-form4_1776459315.xml · nonDerivative · entry 1

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 208,641

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-021543 · wk-form4_1774567271.xml · derivative · entry 3

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,413

Underlying: Common Stock · 5,500 shares

Expires 2023-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-021543 · wk-form4_1774567271.xml · nonDerivative · entry 2

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,286

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.55 to $19.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-021543 · wk-form4_1774567271.xml · nonDerivative · entry 1

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,786

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-020876 · wk-form4_1774395899.xml · derivative · entry 3

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,944

Underlying: Common Stock · 9,200 shares

Expires 2033-04-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following April 5, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-020876 · wk-form4_1774395899.xml · nonDerivative · entry 2

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,355

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.15 to $18.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-020876 · wk-form4_1774395899.xml · nonDerivative · entry 1

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

SEC source: 0001628280-26-020236 · wk-form4_1774040575.xml · derivative · entry 9

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 176,107

Underlying: Common Stock · 1,596 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F5 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-020236 · wk-form4_1774040575.xml · nonDerivative · entry 6

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 339,392

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $19.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-020236 · wk-form4_1774040575.xml · nonDerivative · entry 5

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 340,988

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-020236 · wk-form4_1774040575.xml · derivative · entry 8

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,703

Underlying: Common Stock · 6,905 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F5 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-020236 · wk-form4_1774040575.xml · nonDerivative · entry 4

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 339,392

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $18.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-020236 · wk-form4_1774040575.xml · nonDerivative · entry 3

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 346,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-020236 · wk-form4_1774040575.xml · derivative · entry 7

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,608

Underlying: Common Stock · 6,499 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F5 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-020236 · wk-form4_1774040575.xml · nonDerivative · entry 2

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 339,392

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $19.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-020236 · wk-form4_1774040575.xml · nonDerivative · entry 1

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 345,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-018934 · wk-form4_1773783415.xml · derivative · entry 4

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,334

Underlying: Common Stock · 8,000 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-018934 · wk-form4_1773783415.xml · nonDerivative · entry 3

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 200,641

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.34 to $19.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-018934 · wk-form4_1773783415.xml · nonDerivative · entry 2

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,141

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.34 to $19.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-018934 · wk-form4_1773783415.xml · nonDerivative · entry 1

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-016874 · wk-form4_1773262035.xml · derivative · entry 3

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 191,107

Underlying: Common Stock · 36,766 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-016874 · wk-form4_1773262035.xml · nonDerivative · entry 2

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 339,392

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $19.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-016874 · wk-form4_1773262035.xml · nonDerivative · entry 1

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 376,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-015778 · wk-form4_1772843254.xml · derivative · entry 9

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 227,873

Underlying: Common Stock · 3,817 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F5 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-015778 · wk-form4_1772843254.xml · nonDerivative · entry 6

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 339,392

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $18.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-015778 · wk-form4_1772843254.xml · nonDerivative · entry 5

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 343,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-015778 · wk-form4_1772843254.xml · derivative · entry 8

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 231,690

Underlying: Common Stock · 1,786 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F5 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-015778 · wk-form4_1772843254.xml · nonDerivative · entry 4

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 339,392

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $18.795, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0001628280-26-015778 · wk-form4_1772843254.xml · nonDerivative · entry 3

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 341,178

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0001628280-26-015421 · wk-form4_1772755729.xml · derivative · entry 8

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,784

Underlying: Common Stock · 2,963 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F5 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0001628280-26-015421 · wk-form4_1772755729.xml · nonDerivative · entry 5

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,355

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.15 to $18.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.